BackNLS Pharmaceutics Overview

NLS Pharmaceutics Research & Development

Research & Development expenses for NLSP.

Quarterly R&D Expenses

$142083.00
↓ 47.64% YoY

As of Jun 30, 2025

Annual R&D Expenses (TTM)

$2.09M
↓ 82.42% YoY

Trailing 12 months ending Jun 30, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin